BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32323737)

  • 1. Downregulation of SETD7 promotes migration and invasion of lung cancer cells via JAK2/STAT3 pathway.
    Cao L; Ren Y; Guo X; Wang L; Zhang Q; Li X; Wu X; Meng Z; Xu K
    Int J Mol Med; 2020 May; 45(5):1616-1626. PubMed ID: 32323737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression.
    Li X; Na H; Xu L; Zhang X; Feng Z; Zhou X; Cui J; Zhang J; Lin F; Yang S; Yue F; Mousa H; Zuo Y
    Biomed Pharmacother; 2020 Jan; 121():109644. PubMed ID: 31766099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of ALK4 inhibits cell proliferation and migration through the inactivation of JAK/STAT3 signaling pathway in glioma.
    Song C; Fan B; Xiao Z
    Biomed Pharmacother; 2018 Feb; 98():440-445. PubMed ID: 29278854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
    Zhong L; Sun S; Shi J; Cao F; Han X; Chen Z
    Tumour Biol; 2017 Jun; 39(6):1010428317697579. PubMed ID: 28631574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silibinin downregulates MMP2 expression via Jak2/STAT3 pathway and inhibits the migration and invasive potential in MDA-MB-231 cells.
    Byun HJ; Darvin P; Kang DY; Sp N; Joung YH; Park JH; Kim SJ; Yang YM
    Oncol Rep; 2017 Jun; 37(6):3270-3278. PubMed ID: 28440514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and the potential functions of TRIM32 in lung cancer tumorigenesis.
    Yin H; Li Z; Chen J; Hu X
    J Cell Biochem; 2019 Apr; 120(4):5232-5243. PubMed ID: 30378152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of autophagy potentiates the anti-metastasis effect of phenethyl isothiocyanate through JAK2/STAT3 pathway in lung cancer cells.
    Wang H; Wang L; Cao L; Zhang Q; Song Q; Meng Z; Wu X; Xu K
    Mol Carcinog; 2018 Apr; 57(4):522-535. PubMed ID: 29278657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL21/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2/STAT3 signaling pathway.
    Chen Y; Shao Z; Jiang E; Zhou X; Wang L; Wang H; Luo X; Chen Q; Liu K; Shang Z
    J Cell Physiol; 2020 Sep; 235(9):5995-6009. PubMed ID: 32017846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascade.
    Lv J; Wu Q; Li K; Bai K; Yu H; Zhuang J; Sun H; Yang H; Yang X; Lu Q
    Int J Biol Sci; 2023; 19(12):3744-3761. PubMed ID: 37564199
    [No Abstract]   [Full Text] [Related]  

  • 10. REX1 promotes EMT-induced cell metastasis by activating the JAK2/STAT3-signaling pathway by targeting SOCS1 in cervical cancer.
    Zeng YT; Liu XF; Yang WT; Zheng PS
    Oncogene; 2019 Oct; 38(43):6940-6957. PubMed ID: 31409905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of SOX18 inhibits laryngeal carcinoma cell proliferation, migration, and invasion through JAK2/STAT3 signaling.
    Xu Y; Zhang Q; Zhou J; Li Z; Guo J; Wang W; Wang W
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31189744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of STAT3 and vitamin D receptor in EZH2-mediated invasion of human colorectal cancer.
    Lin YW; Ren LL; Xiong H; Du W; Yu YN; Sun TT; Weng YR; Wang ZH; Wang JL; Wang YC; Cui Y; Sun DF; Han ZG; Shen N; Zou W; Xu J; Chen HY; Cao W; Hong J; Fang JY
    J Pathol; 2013 Jul; 230(3):277-90. PubMed ID: 23424038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salidroside inhibits migration, invasion and angiogenesis of MDA‑MB 231 TNBC cells by regulating EGFR/Jak2/STAT3 signaling via MMP2.
    Kang DY; Sp N; Kim DH; Joung YH; Lee HG; Park YM; Yang YM
    Int J Oncol; 2018 Aug; 53(2):877-885. PubMed ID: 29901185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SETD7 promotes metastasis of triple-negative breast cancer by YY1 lysine methylation.
    Gao L; Zhang J; Long Q; Yang Y; Li Y; Li G; Pu P; Tong S; He Y; Li Q; Chen Y; Liu Y; Kong X
    Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166780. PubMed ID: 37286143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma.
    Cao HH; Chu JH; Kwan HY; Su T; Yu H; Cheng CY; Fu XQ; Guo H; Li T; Tse AK; Chou GX; Mo HB; Yu ZL
    Sci Rep; 2016 Feb; 6():21731. PubMed ID: 26911838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA PICART1 suppresses proliferation and promotes apoptosis in lung cancer cells by inhibiting JAK2/STAT3 signaling.
    Zhao JM; Cheng W; He XG; Liu YL; Wang FF; Gao YF
    Neoplasma; 2018 Sep; 65(5):779-789. PubMed ID: 29940776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Non-Coding RNAs (lncRNAs) Tumor-Suppressive Role of lncRNA on Chromosome 8p12 (TSLNC8) Inhibits Tumor Metastasis and Promotes Apoptosis by Regulating Interleukin 6 (IL-6)/Signal Transducer and Activator of Transcription 3 (STAT3)/Hypoxia-Inducible Factor 1-alpha (HIF-1α) Signaling Pathway in Non-Small Cell Lung Cancer.
    Fan H; Li J; Wang J; Hu Z
    Med Sci Monit; 2019 Oct; 25():7624-7633. PubMed ID: 31601776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of microRNA-608 on lung cancer cell proliferation, migration, and invasion by targeting BRD4 through the JAK2/STAT3 pathway.
    Xu W; Sun D; Wang Y; Zheng X; Li Y; Xia Y; Teng Y
    Bosn J Basic Med Sci; 2020 Aug; 20(3):347-356. PubMed ID: 31621555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.
    Zheng L; Chen J; Zhou Z; He Z
    Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-34b inhibits the migration/invasion and promotes apoptosis of non-small-cell lung cancer cells by YAF2.
    Zhuang XF; Zhao LX; Guo SP; Wei S; Zhai JF; Zhou QH
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2038-2046. PubMed ID: 30915747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.